Concerned about an AI bubble? Sign up for The Daily Upside for smart and actionable market news, built for investors. Who's calling the shots? Last week, REX Shares launched the REX Peptide ETF (PEPT), which holds companies (including pharma giants Eli Lilly and Novo Nordisk) that develop and manufacture peptide products, like GLP-1s. AdvisorShares has filed for a competing product, the Peptide and Human Enhancement ETF. There is a growing list of products that try to cash in on the wellness zeitgeist — but much as with GLP-1 users, appetite may be suppressed.
Chung toi hien cong khai y chinh. Tao tai khoan mien phi de doc toan bo bai viet, luu, thao luan va ket noi voi boi canh thi truong va OSINT.